Figure 2From: Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancerPre- and post-treatment (A) PSA levels, (B) total testosterone levels, and (C) PSA/testosterone ratios for all patients. Error bars indicate 95% confidence intervals.Back to article page